Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Purine-Alkylator Combination In Follicular Lymphoma Immuno-Chemotherapy for Older Patients: a Phase III Comparison of First-line R-CVP Versus R-FC

NCT01303887 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT01303887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Purine-Alkylator Combination In Follicular Lymphoma Immuno-Chemotherapy for Older Patients: a Phase III Comparison of First-line R-CVP Versus R-FC
Lead sponsor
University of Liverpool
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
May 11, 2023
Enrollment
680 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma